Search Results - Robert A. Wolff
- Showing 1 - 20 results of 119
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients With Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas by Maria A. Kouvaraki, Jaffer A. Ajani, Paulo M. Hoff, Robert A. Wolff, Douglas B. Evans, Richard D. Lozano, James C. Yao
Published 2004Artigo -
13
A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer by Paulo M. Hoff, Scott Kopetz, Melanie B. Thomas, Adrian Langleben, David Rinaldi, Lowell Anthony, Robert A. Wolff, Yvonne Lassere, James L. Abbruzzese
Published 2008Artigo -
14
Phase II Study of Capecitabine and Oxaliplatin for Advanced Adenocarcinoma of the Small Bowel and Ampulla of Vater by Michael J. Overman, Gauri R. Varadhachary, Scott Kopetz, Rosni Adinin, E. Lin, Jeffrey S. Morris, Cathy Eng, James L. Abbruzzese, Robert A. Wolff
Published 2009Artigo -
15
Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Thera... by Christopher H. Crane, Kathryn Winter, William F. Regine, Howard Safran, Tyvin A. Rich, Walter J. Curran, Robert A. Wolff, Christopher G. Willett
Published 2009Artigo -
16
-
17
Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial by Henry Q. Xiong, Arthur Rosenberg, Albert F. LoBuglio, William Schmidt, Robert A. Wolff, John C. Deutsch, Michael N. Needle, James L. Abbruzzese
Published 2004Artigo -
18
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma by Reham Abdel‐Wahab, Gauri R. Varadhachary, Priya Bhosale, Xuemei Wang, David R. Fogelman, Rachna T. Shroff, Michael J. Overman, Robert A. Wolff, Milind Javle
Published 2018Artigo -
19
Chemotherapy with 5‐fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma by Michael J. Overman, Scott Kopetz, Sijin Wen, Paulo M. Hoff, David R. Fogelman, Jeffrey S. Morris, James L. Abbruzzese, Jaffer A. Ajani, Robert A. Wolff
Published 2008Artigo -
20
Search Tools:
Related Subjects
Medicine
Internal medicine
Cancer
Oncology
Pancreatic cancer
Adenocarcinoma
Gastroenterology
Biology
Colorectal cancer
Chemotherapy
Surgery
Breast cancer
Cancer research
Gene
Pancreas
Genetics
Gemcitabine
Neoadjuvant therapy
Confidence interval
Radiation therapy
KRAS
Paleontology
Clinical trial
Environmental health
Population
Radiology
Stage (stratigraphy)
Capecitabine
Multivariate analysis
Pancreatic ductal adenocarcinoma